Pancreatic β-cell K(ATP) channel activity and membrane-binding studies with nateglinide: A comparison with sulfonylureas and repaglinide

Journal of Pharmacology and Experimental Therapeutics

Volumn 293, Issue 2, 2000, Pages 444-452

  Hu, Shiling ^a   Wang, Shuya ^a   Fanelli, Barbara ^a   Bell, Philip A ^a   Dunning, Beth E ^a   Geisse, Sabine ^b   Schmitz, Rita ^b   Boettcher, Brian R ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; NATEGLINIDE; POTASSIUM CHANNEL; REPAGLINIDE; SULFONYLUREA DERIVATIVE; SULFONYLUREA RECEPTOR; TOLBUTAMIDE;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RAT;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BINDING, COMPETITIVE; CARBAMATES; CELL MEMBRANE; CELL SEPARATION; CELLS, CULTURED; CYCLOHEXANES; GLUCOSE; GLYBURIDE; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; KINETICS; MALE; MEMBRANE PROTEINS; PATCH-CLAMP TECHNIQUES; PHENYLALANINE; PIPERIDINES; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RATS; RATS, SPRAGUE-DAWLEY; REPRESSOR PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; SULFONYLUREA COMPOUNDS;

EID: 0034053981     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. ATP channels. Physiol Rev 78:227-245.
2. Aguilar-Bryan L, Nelson DA, Vu QA, Humphrey MB and Boyd AE (1990) Photoaffinity labeling and partial purification of the beta cell sulfonylurea receptor using a novel, biologically active glyburide analog. J Biol Chem 265:8218-8224.
3. ATP channels in hamster insulinoma tumor (HIT) cells. Evidence for direct association of the receptor with the channel. J Biol Chem 267:14934-14940.
4. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP, Boyd AE, Gonzalez G, Herrera-Sosa H, Nguy K, Bryan J and Nelson DA (1995) Cloning of the beta cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. Science (Wash DC) 268:423-426.
5. Akiyoshi M, Kakei M, Nakazaki M and Tanaka H (1995) A new hypoglycemic agent, A-4166, inhibits ATP-sensitive potassium channels in rat pancreatic beta-cells. Am J Physiol 268:E185-E193.
6. Bennett JP Jr (1978) Methods in binding studies, in Neurotransmitter Receptor Binding (Yamamura HI, Enna SJ and Kuhar MJ eds) pp 57-90, Raven Press, New York.
7. Bhathena SJ, Awoke S, Voyles NR, Wilkins SD, Recant L, Oie HK and Gazdar AF (1984) Insulin, glucagon, and somatostatin secretion by cultured rat islet cell tumor and its clones. Proc Soc Exp Biol Med 175:35-38.
8. DeSouza CJ, Russo P, Lozito R and Dunning B (1997) The metabolic advantages of a rapid onset/short acting insulin secretagogue on prandial glucose excursions (Abstract). Diabetes 46 (Suppl 1):A241.
9. + channels in an insulin-secreting cell line. J Membr Biol 99:215-224.
10. Dunne MJ and Petersen OH (1991) Potassium selective ion channels in insulin-secreting cells: Physiology, pharmacology and other role in stimulus-secretion coupling. Biochim Biophys Acta 1071:67-82.
11. Ferst A (1985) Enzyme Structure and Mechanism, 2nd ed., pp 150-151, WH Freeman and Co, New York.
12. Forget RS, Martin JE and Cote RH (1993) A centrifugal separation procedure detects moderate affinity cGMP binding sites in membrane-associated proteins and permeabilized cells. Anal Biochem 215:159-161.
13. Frøkjær-Jensen J, Kofod H and Godtfredsen SE (1992) Mechanism of action of AG-EE 623 ZW, a novel insulinotropic agent (Abstract). Diabetologia 35 (Suppl 1):A116.
14. Fuhlendorff J, Rorsman P, Kofod H, Brand CL, Rolin B, MacKay P, Shymko R and Carr RD (1998) Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes 47:345-351.
15. Fujita T, Seta Y, Kondo N and Kata R (1996) Studies on the N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine (A-4166) receptor in HIT T-15 cells. Biochem Pharmacol 52:407-411.
16. Gaines KL, Hamilton S and Boyd AE (1988) Characterization of the sulfonylurea receptor on beta cell membranes. J Biol Chem 263:2589-2592.
17. Gromada J, Dissing S, Kofod H and Frøkjær-Jensen J (1995) Effects of the hypoglycemic drugs repaglinide and glibenclamide on ATP-sensitive potassium-channels and cytosolic calcium levels in beta TC3 cells and rat pancreatic beta cells. Diabetologia 38:1025-1032.
18. Hamill OP, Marty A, Neher E, Sakmann B and Sigworth FJ (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pfluegers Arch 391:85-100.
19. Ikenoue T, Akiyoshi M, Fujitani S, Okazaki K, Kondo N and Maki T (1997) Hypoglycaemic and insulinotropic effects of a novel oral antidiabetic agent, (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-phenylalanine (A-4166). Br J Pharmacol 120:137-145.
20. Jijakli H, Ulusoy S and Malaisse WJ (1996) Dissociation between the potency and reversibility of the insulinotropic action of two meglitinide analogues. Pharmacol Res 34:105-108.
21. Jijakli H, Ulusoy S and Malaisse WJ (1997) Dynamics of the cationic and secretory responses to A-4166 in perifused pancreatic islets. Fundam Clin Pharmacol 11: 300-304.
22. Lebrun P and Malaisse WJ (1992) Cationic and secretory effects of glimepiride and glibenclamide in perifused rat iselts. Pharmacol Toxicol 70:357-360.
23. LoGrasso P, Cornell-Kennon S and Boettcher BR (1994) Comparison of the inhibition of yeast, rat, and human squalene synthase. Bioorg Chem 22:294-299.
24. Loubatières A (1977) Effects of sulfonylureas on the pancreas, in Diabetic Pancreas (Volk BW and Wellmann KF eds) pp 489-515, Plenum Press, New York.
25. Malaisse WJ (1995) Stimulation of insulin release by non-sulfonylurea hypoglycemic agents: The meglitinide family. Horm Metab Res 27:263-266.
26. Mark M and Grell W (1997) Hypoglycemic effects of the novel antidiabetic agent repaglinide in rat and dogs. Br J Pharmacol 121:1597-1604.
27. McPherson GA (1989) A mathematical approach to receptor characterization, in Receptor Pharmacology and Function (Williams M, Glennon RA and Timmermans PBMWM eds) pp 47-84, Marcel Dekker, New York.
28. Müller G, Hartz D, Punter J, Okonomopulos R and Kramer W (1994) Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. Biochem Biophys Acta 1191:267-277.
29. 86Rb efflux and glibenclamide binding. Pfluegers Arch 415:47-55.
30. Pipeleers DG, Veld PA, Van De Winkel M, Maes E, Schuit FC and Gepts W (1985) A new in vitro model for the study of pancreatic A and B cells. Endocrinology 117:806-816.
31. Ronner P, Hang TL, Kraebber MJ and Higgins TJ (1992) Effect of the hypoglycaemic drug (-)-AZ-DF-265 on ATP-sensitive potassium channels in rat pancreatic beta-cells. Br J Pharmacol 106:250-255.
32. Sato Y, Fujita H, Dan K, Fujita T and Kato R (1995) Stimulating activity of A-4166 on insulin release in in situ hamster pancreatic perfusion. Pharmacology 51:245-253.
33. + channel in insulin-secreting cells. J Biol Chem 262:15840-15844.
34. Shinkai H, Nishikawa M, Sato Y, Toi K, Kumashiro I, Seto Y, Fukuma M, Dan K and Toyoshima S (1989) N-(cyclohexylcarbonyl)-D-phenylalanines and related compounds. A new class of oral hypoglycemic agents. 2. J Med Chem 32:1436-1441.
35. Sturgess NC, Ashford MLJ, Cook DL and Hales CN (1985) The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet 2:474-475.
36. Sugita O, Sawada Y, Sugiyama Y, Iga T and Hanano M (1981) Prediction of drug-drug interaction from in vitro plasma protein binding and metabolism. A study of tolbutamide-sulfonamide interaction in rats. Biochem Pharmacol 30: 3347-3354.
37. Titeler M (1989) Receptor binding theory and methodology, in Receptor Pharmacology and Function (Williams M, Glennon R and Timmermans PBMWM eds) pp 17-45, Marcel Dekker, New York.